LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression.
Lubben N, Brynildsen JK, Webb CM, Li HL, Leyns CEG, Changolkar L, Zhang B, Meymand ES, O'Reilly M, Madaj Z, DeWeerd D, Fell MJ, Lee VMY, Bassett DS, Henderson MX.
Lubben N, et al. Among authors: henderson mx.
Transl Neurodegener. 2024 Mar 4;13(1):13. doi: 10.1186/s40035-024-00403-2.
Transl Neurodegener. 2024.
PMID: 38438877
Free PMC article.